Investing Acceleration of RAD204 Phase 1 dose escalation trial by admin May 12, 2025 May 12, 2025 Radiopharm Theranostics (RAD:AU) has announced Acceleration of RAD204 Phase 1 dose escalation trial Download the PDF here. This post appeared first on investingnews.com previous post Multiple New Multi-Commodity Targets next post Excellent Gold Intersections Verified at Kiimala Project You may also like Uranium Stocks: 5 Biggest Companies in 2025 May 20, 2025 Hazer and KBR Enter Global Deal to Accelerate... May 5, 2025 NorthStar Gaming Changes Date of Q4 and Year-End... April 25, 2025 Crypto Market Recap: $TRUMP Token Soars as President... April 27, 2025 Q1 2025 Management’s Discussion and Analysis May 14, 2025 Manindi Ti-V-Fe Discovery Delivers High-Grade Concentrates May 16, 2025 WCN Raises A$14.4M at an Average 29% Premium... May 19, 2025 Top 5 Canadian Mining Stocks This Week: Group... May 11, 2025 Spodumene Pegmatite Discovered at Agboville and Rubino May 22, 2025 Investing in Uranium ETFs: 9 Options for Uranium... May 10, 2025